期刊文献+

格列美脲联合参芪降糖胶囊对2型糖尿病血糖波动的影响 被引量:4

暂未订购
导出
摘要 目的:观察格列美脲胶囊联合参芪降糖胶囊对2型糖尿病患者血糖波动的影响。方法:采用葡萄糖氧化酶电极法对78例格列美脲治疗的2型糖尿病患者联合参芪降糖胶囊治疗2周前后进行连续空腹及餐前、餐后血糖监测,比较治疗前后血糖的波动变化。结果:加用参芪降糖胶囊后,空腹血糖及餐后血糖均有所下降(P<0.05)。空腹血糖与餐后血糖的波动幅度明显降低(P<0.01)。治疗前后比较,低血糖的发生率减少。结论:格列美脲胶囊联合参芪降糖胶囊可以明显降低2型糖尿病血糖的波动,使血糖调整得更平稳,同时也能使低血糖的发生率减少。
出处 《中国当代医药》 2010年第23期40-40,43,共2页 China Modern Medicine
  • 相关文献

参考文献3

二级参考文献15

  • 1魏爱生,王甫能,陈苹,郅敏,陈发胜,郎江明.甘精胰岛素联合格列美脲及阿卡波糖治疗2型糖尿病患者24小时动态血糖变化[J].中华内分泌代谢杂志,2006,22(4):325-326. 被引量:104
  • 2苏胜偶,赵家军,张锦,邹大进,李红,盛正妍,梁干雄,Harald Landen.阿卡波糖治疗在日常临床工作中的有效性、安全性和被接受程度——对中国2型糖尿病患者的阿卡波糖上市后监测(英文)[J].中华内分泌代谢杂志,2006,22(6). 被引量:16
  • 3Kahn SE. The importance of the beta - cell in the pathogenesis of type 2 diabetes mellitus. Am J Med 2000;108:21 -81.
  • 4Simonson DC,KourdesL,Fischette CT. Efficacy and safety of glip izide GITS in the treatment of non - insulin - dependent diaetesmellitus. Diabetes 1994 ;43 :.
  • 5Molnar GD,Taylor WF,Ho MM.Day-to-day variation of continuously monitored glycaemia:a further measure of diabetic instability.Diabetologia,1972,8:342-348.
  • 6Muggeo M,Zoppiui G,Bonora E,et al.Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients:the Verona Diabetes Study.Diabetes Care,2000,23:45-50.
  • 7Service FJ,Molnar GD,Rosevear JW,et al.Mean amplitude of glycemic excursions,a measure of diabetic instability.Diabetes,1970,19:644-655.
  • 8Schlichtkrull J,Munck O,Jersild M.The M-value,an index of bloodsugar control in diabetes.Acta Med Scan,1965,177:95-102.
  • 9Mirouze J,Satingher A,Sany C,et al.Insulin efficiency coefficient:M coefficient of Schlichtkrull corrected and simplified by the continuous blood glucose recording technic.Diabete,1963,11:267-273.
  • 10Kovatchev BP,Cox DJ,Gonder-Frederick LA,et al.Symetrization of the blood glucose measurement scale and its applications.Diabetes Care,1997,20:1655-1658.

共引文献22

同被引文献60

  • 1尤玉玲,郭伟玲,杨美,高佩国.参芪降糖散治疗2型糖尿病42例[J].中国疗养医学,2011,20(8):750-750. 被引量:1
  • 2刘芳,徐火根,姚庆姑,徐东丽,陈影,谢连红.二甲双胍可降低超重和单纯性肥胖患者的瘦素水平[J].复旦学报(医学版),2003,30(3):251-254. 被引量:14
  • 3杨帆,张学军.2型糖尿病药物治疗新进展[J].实用医院临床杂志,2010,7(4):19-21. 被引量:7
  • 4谢群莉,尤婷,戴淑萍.口服降糖药的临床应用[J].海峡药学,2007,19(6):85-87. 被引量:8
  • 5中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010)版[M].北京:北京大学医学出版社,2011.
  • 6Zanchi A,Lehmann R,Philippe J.Antidiabetic drugs and kidney disease-recommendation of the Swiss Society for Endocrinology and Diabetology[J].Swiss Med Wkly,2012,142,w13629.
  • 7Holman RR,Paul SK,Bethel MA,et al.10-year follow-up offintensive glucose control in type 2 Diabetes[J].New Engl J Med,2008,359:1577-1589.
  • 8Hattori Y,Suzuki K,Hattori S,et al.Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells[J].Hypertension,2006,47(6):1183-1188.
  • 9Davis BJ,Xie Z,Viollet B,et al.Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase[J].Diabetes,2006,55(2):496-505.
  • 10徐明彤.新型口服降糖药及口服降糖药新剂型[J].药品评价,2008,5(4):160-163. 被引量:12

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部